TRACON Pharmaceuticals Inc (TCON)
1.862
+0.04
(+2.30%)
USD |
NASDAQ |
Apr 23, 16:00
1.88
+0.02
(+0.97%)
Pre-Market: 08:12
TRACON Pharmaceuticals Cash from Financing (TTM): -12.54M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -12.54M |
September 30, 2023 | -8.918M |
June 30, 2023 | 10.64M |
March 31, 2023 | 14.55M |
December 31, 2022 | 19.68M |
September 30, 2022 | 14.03M |
June 30, 2022 | 16.32M |
March 31, 2022 | 10.73M |
December 31, 2021 | 10.56M |
September 30, 2021 | 24.58M |
June 30, 2021 | 28.09M |
March 31, 2021 | 32.89M |
December 31, 2020 | 36.76M |
September 30, 2020 | 25.06M |
June 30, 2020 | 8.09M |
March 31, 2020 | 3.94M |
December 31, 2019 | 0.906M |
September 30, 2019 | -0.681M |
Date | Value |
---|---|
June 30, 2019 | 0.003M |
March 31, 2019 | 1.02M |
December 31, 2018 | 35.32M |
September 30, 2018 | 36.22M |
June 30, 2018 | 38.77M |
March 31, 2018 | 37.73M |
December 31, 2017 | 3.326M |
September 30, 2017 | 17.69M |
June 30, 2017 | 19.16M |
March 31, 2017 | 19.28M |
December 31, 2016 | 19.41M |
September 30, 2016 | 6.202M |
June 30, 2016 | 2.241M |
March 31, 2016 | 1.367M |
December 31, 2015 | 36.45M |
September 30, 2015 | 33.37M |
June 30, 2015 | 60.53M |
March 31, 2015 | 66.13M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-12.54M
Minimum
Dec 2023
36.76M
Maximum
Dec 2020
12.35M
Average
10.73M
Median
Mar 2022
Cash from Financing (TTM) Benchmarks
BioSig Technologies Inc | 17.33M |
Revolution Medicines Inc | 1.229B |
Perspective Therapeutics Inc | 0.785M |
Electromed Inc | -0.128M |
Xtant Medical Holdings Inc | 19.69M |